SCHEMBL12004072

SCHEMBL12004072

CC(=O)c1ccc(C(F)(F)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRB2 P62993 1/20 0.50
▸ MAPT P10636 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAOB P27338 2/20 0.46
▸ NR4A1 P22736 1/20 0.46
▸ NR4A2 P43354 1/20 0.46
▸ NR4A3 Q92570 1/20 0.46
▸ HPGD P15428 4/20 0.43
▸ LMNA P02545 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ CES2 O00748 1/20 0.43
▸ CES1 P23141 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ KIF11 P52732 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ SRD5A2 P31213 1/20 0.42
▸ HSD17B1 P14061 1/20 0.42
▸ AKR1C3 P42330 1/20 0.42
▸ AKR1C2 P52895 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13199203 0.84 GRB2 (0.57) GRB2NR4A1NR4A2NR4A3HPGD
SCHEMBL72091 0.80 CES2 (0.67) MAPTSMN1; SMN2MAOBNR4A1NR4A2
SCHEMBL31510803 0.79 GRB2 (0.50) GRB2MAPTMAOBCES2CES1
SCHEMBL1063656 0.79 TSHR (0.53) MAPTLMNARAB9AL3MBTL1KMT2A
SCHEMBL14076375 0.78 SRD5A2 (0.50) GRB2MAPTSMN1; SMN2LMNARAB9A
SCHEMBL18290647 0.78 MAOB (0.49) MAPTSMN1; SMN2MAOBNR4A1NR4A2
SCHEMBL5860009 0.78 GRB2 (0.49) GRB2MAPTSMN1; SMN2LMNARAB9A
SCHEMBL23588301 0.78 CES2 (0.56) GRB2NR4A1NR4A2NR4A3HPGD
SCHEMBL13199251 0.78 GRB2 (0.52) GRB2HPGDCES2CES1KIF11
SCHEMBL15957723 0.78 GRB2 (0.49) GRB2MAPTSMN1; SMN2NR4A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111004122-B Synthesis method of gem-difluoroallyl compound in aqueous phase 陕西科技大学 2022-03-04 — — CN disclosed
CN-111004122-A Synthesis method of gem-difluoroallyl compound in aqueous phase 陕西科技大学 2020-04-14 — — CN disclosed
US-8802886-B2 Method for producing aromatic difluoroacetic acid ester CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-12 — — US disclosed
US-8802886-B2 Method for producing aromatic difluoroacetic acid ester CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-12 — — US disclosed
US-8802886-B2 Method for producing aromatic difluoroacetic acid ester CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-12 — — US disclosed
EP-2502898-A1 PREPARATION METHOD FOR AROMATIC DIFLUOROACETIC ACID ESTER Central Glass Company, Limited (JP) 2012-09-26 — — EP disclosed
US-20120220795-A1 METHOD FOR PRODUCING AROMATIC DIFLUOROACETIC ACID ESTER CENTRAL GLASS COMPANY, LIMITED (JP) 2012-08-30 — — US disclosed
US-20120220795-A1 METHOD FOR PRODUCING AROMATIC DIFLUOROACETIC ACID ESTER CENTRAL GLASS COMPANY, LIMITED (JP) 2012-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220795-A1 METHOD FOR PRODUCING AROMATIC DIFLUOROACETIC ACID ESTER DDC, AADAC, FNTB GRB2 2578/4885MAPT 3444/4885SMN1; SMN2 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback